Company Details
astellaspharmainc
12,110
671,790
3254
astellas.com
0
AST_1093412
In-progress


Astellas Pharma Company CyberSecurity Posture
astellas.comAstellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines
Company Details
astellaspharmainc
12,110
671,790
3254
astellas.com
0
AST_1093412
In-progress
Between 750 and 799

Astellas Pharma Global Score (TPRM)XXXX



No incidents recorded for Astellas Pharma in 2026.
No incidents recorded for Astellas Pharma in 2026.
No incidents recorded for Astellas Pharma in 2026.
Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines


Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline t
Fundada há mais de 60 anos e com capital 100% nacional, a EMS é a líder do mercado farmacêutico brasileiro há 19 anos consecutivos, pertencente ao Grupo NC, um dos maiores conglomerados brasileiros. A empresa ocupa também a liderança no segmento de genéricos desde 2013 (IQVIA 2019) e está entre os

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldw

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio an
.png)
Explore Astellas careers and job openings worldwide, and join a team driven by science, collaboration, and a mission to improve patients' lives.
The summit's agenda is crafted to provide insights necessary for embracing impactful change in today's rapidly evolving digital landscape.
Before companies and investors look towards the future, they must first understand the opportunities and challenges AI presents to them.
Eisai is the latest drugmaker to be hit with a ransomware attack. The Japanese company said it “immediately” set up a company-wide task force after suffering a...
Leqembi scored an FDA priority review. Enhertu showed pan-tumor activity in a key trial. The FDA sent a long Form 483 to Cipla. Plus more.
The company's cybersecurity business is growing, but CEO Satya Nadella warned that customers, in an uncertain economy, are exercising...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Astellas Pharma is http://www.astellas.com/.
According to Rankiteo, Astellas Pharma’s AI-generated cybersecurity score is 799, reflecting their Fair security posture.
According to Rankiteo, Astellas Pharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Astellas Pharma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
According to Rankiteo, Astellas Pharma is not certified under SOC 2 Type 1.
According to Rankiteo, Astellas Pharma does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Astellas Pharma is not listed as GDPR compliant.
According to Rankiteo, Astellas Pharma does not currently maintain PCI DSS compliance.
According to Rankiteo, Astellas Pharma is not compliant with HIPAA regulations.
According to Rankiteo,Astellas Pharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Astellas Pharma operates primarily in the Pharmaceutical Manufacturing industry.
Astellas Pharma employs approximately 12,110 people worldwide.
Astellas Pharma presently has no subsidiaries across any sectors.
Astellas Pharma’s official LinkedIn profile has approximately 671,790 followers.
Astellas Pharma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
No, Astellas Pharma does not have a profile on Crunchbase.
Yes, Astellas Pharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/astellaspharmainc.
As of January 24, 2026, Rankiteo reports that Astellas Pharma has not experienced any cybersecurity incidents.
Astellas Pharma has an estimated 5,512 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Astellas Pharma has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
Typemill is a flat-file, Markdown-based CMS designed for informational documentation websites. A reflected Cross-Site Scripting (XSS) exists in the login error view template `login.twig` of versions 2.19.1 and below. The `username` value can be echoed back without proper contextual encoding when authentication fails. An attacker can execute script in the login page context. This issue has been fixed in version 2.19.2.
A DOM-based Cross-Site Scripting (XSS) vulnerability exists in the DomainCheckerApp class within domain/script.js of Sourcecodester Domain Availability Checker v1.0. The vulnerability occurs because the application improperly handles user-supplied data in the createResultElement method by using the unsafe innerHTML property to render domain search results.
A Remote Code Execution (RCE) vulnerability exists in Sourcecodester Modern Image Gallery App v1.0 within the gallery/upload.php component. The application fails to properly validate uploaded file contents. Additionally, the application preserves the user-supplied file extension during the save process. This allows an unauthenticated attacker to upload arbitrary PHP code by spoofing the MIME type as an image, leading to full system compromise.
A UNIX symbolic link following issue in the jailer component in Firecracker version v1.13.1 and earlier and 1.14.0 on Linux may allow a local host user with write access to the pre-created jailer directories to overwrite arbitrary host files via a symlink attack during the initialization copy at jailer startup, if the jailer is executed with root privileges. To mitigate this issue, users should upgrade to version v1.13.2 or 1.14.1 or above.
An information disclosure vulnerability exists in the /srvs/membersrv/getCashiers endpoint of the Aptsys gemscms backend platform thru 2025-05-28. This unauthenticated endpoint returns a list of cashier accounts, including names, email addresses, usernames, and passwords hashed using MD5. As MD5 is a broken cryptographic function, the hashes can be easily reversed using public tools, exposing user credentials in plaintext. This allows remote attackers to perform unauthorized logins and potentially gain access to sensitive POS operations or backend functions.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.